NanoSMS: single molecule secretome analysis for non-destructive cellular fingerprinting
NanoSMS: single molecule secretome analysis for non-destructive cellular fingerprinting
批准号:
10713935
负责人:
Kevin Freedman
金额:
$34.69万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2028-08-31
关键词:
AntibodiesAntibody FormationAntigensAutoimmune DiseasesB-LymphocytesBiologyCell CommunicationCell LineageCell TherapyCell physiologyCellsCollectionComplexDevelopmentDiseaseEncapsulatedEnvironmentFingerprintGlassHumanImmune responseLifeMalignant NeoplasmsMeasurementMeasuresMethodologyModernizationPatientsPlasma CellsPlayPopulationProteinsRNARegenerative MedicineRetinal blind spotRoleSlideT-LymphocyteTechniquesTechnologyTimeVesiclecancer celleosinophilextracellularinsightmacromoleculenanoporenew technologysingle moleculestem cellstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Over the next 5 years, NanoSMS will be developed into a technology which offers the first look
into the single cell secretome; with single molecule sensitivity. The development of this new
technology is based on the integration of single cell encapsulation technologies with nanopore-
based single molecule sensing. The collection of molecules released into the extracellular
environment by single cells, termed the single cell secretome, offers a unique glimpse into the
complexities of cellular life and cell-to-cell communication. The key features of the technology
which will be developed at the end of the project period include (1) a massively parallel way to
form droplets adhered onto a glass slide and containing a single cell, and (2) a nanopore-based
approach for measuring secreted molecule originating from a single cell. Once the nanopores and
related methodologies are developed, we aim to answer four key questions surrounding important
biomedical issues. First, the nanopore will quantify single cell antibody production originating
from human plasma cells which have been isolated from patients in various disease states
including auto-immune disorders. Second, B cells and T cells will be co-incubated and stimulated
with a single antigen to induce an immune response. The time lag to start generating antibodies
as well as the factors which influence the timing of the immune response will be studied. Third,
eosinophils co-incubated with a single cancer cell (or cancer-derived vesicles) will be investigated
to provide insight into early cancer recognition mechanisms. Lastly, single cell secretome
fingerprinting will be used to access the ability to discriminate between stem cell lineages in a
non-destructive manner. Stem cell characterization is important for cell therapy (in which the
mechanism of action is secreted molecules) as well as assessing cell state for regenerative
medicine. Needless to say, the secretome plays a functional and yet obscured role in both normal
and diseased cellular states. The application of NanoSMS (a nanopore-based approach towards
secretome analysis) will provide a unique and new tool for single cell characterization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金